Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-23-009576
Filing Date
2023-07-13
Accepted
2023-07-13 16:57:22
Documents
1
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 g711230sc13ga2.htm SC 13G/A 86354
  Complete submission text file 0001214659-23-009576.txt   87972
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

EIN.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Subject) CIK: 0001722926 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91181 | Film No.: 231087270
SIC: 2834 Pharmaceutical Preparations